| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Rosenwald (Lindsay A)
INSIDER
|
4.587m | 13.77% | — | Apr 16 2026 |
| 2 |
Highbridge Capital Management, LLC
|
2.735m | 8.21% | +2.735m | Mar 31 2026 |
| 3 |
Weiss (Michael S)
INSIDER
|
2.277m | 6.83% | — | Apr 16 2026 |
| 4 |
Millennium Management LLC
|
1.779m | 5.34% | +1.779m | Aug 26 2026 |
| 5 |
Vanguard Capital Management, LLC
|
1.037m | 3.11% | +71.173k | Jun 30 2026 |
|
1
Rosenwald (Lindsay A)
INSIDER
|
13.77%
4.587m
|
|
2
Highbridge Capital Management, LLC
|
8.21%
2.735m
|
|
3
Weiss (Michael S)
INSIDER
|
6.83%
2.277m
|
|
4
Millennium Management LLC
|
5.34%
1.779m
|
|
5
Vanguard Capital Management, LLC
|
3.11%
1.037m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 37.27% of Fortress Biotech, Inc., with Rosenwald (Lindsay A) the biggest at 13.77%, followed by Highbridge Capital Management, LLC (8.21%) and Weiss (Michael S) (6.83%). |
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Nov 19 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Nov 16 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Nov 12 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Nov 07 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Nov 01 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Oct 25 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Nov 19 2026
$182.45
|
|
Sarah Chen
SALES
|
Nov 16 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Nov 12 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Nov 07 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Nov 01 2026
$170.50
|
|
Lisa Park
SALES
|
Oct 25 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Fortress Biotech, Inc. has held steady at around 17.8% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


